ERBB2 and neoplasm: The assay integrates clinical information (i.e., tumour size and nodal status) with biological information tracking immune response, luminal differentiation, tumour cell proliferation and expression of the HER2 17q12-21 chromosomal amplicon, including the ERBB2 gene.20